High expression of PD-L1 on tumor cells can bind to PD-L1 receptors on immune cells, initiating negative regulatory signals that impair T cell recognition of cancer cells, thereby allowing the tumor cells to evade the immune response (40). This evidence concerns the gene CD274 and cancer.